SBRI funding competition: vaccines for global epidemics - preclinical
Organisations can apply for a share of £25 million to develop new vaccines against infectious diseases.
This competition opened on 17 October 2016 and is now closed for registrations.
The Department of Health is to invest up to £25 million in projects to develop new vaccines against infectious diseases.
This competition aims to support the preclinical development of candidate vaccines against 12 diseases. The UK Vaccine Network has identified these diseases as a priority as they have the potential to cause epidemics in low and middle-income countries.
The competition has two stages:
- Stage 1: exploring the scientific, technical and commercial feasibility of candidate vaccines and vaccine technologies. We expect projects to last for up to 12 months
- Stage 2: carrying out late stage preclinical and early clinical work, based on the results of Stage 1. We expect projects to last for up to 24 months
This is a Small Business Research Initiative (SBRI) competition run in partnership with the Department of Health and the Medical Research Council. It is open to organisations of all sizes. Academic, industry and government bodies may all apply for funding.
You must register before midday (12.00pm) on 21 December 2016.
You must apply before midday (12.00pm) on 4 January 2017.
Not right for your innovation project? View other Innovate UK funding competitions.
Published: 17 October 2016
Updated: 21 December 2016
- Removed the registration link.
- Added the briefing event recording
- Clarified what format attachments 5 & 6 should be, in the guidance
- First published.